BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34302955)

  • 1. SOX17 inhibits proliferation and invasion of neuroblastoma through CXCL12/CXCR4 signaling axis.
    Wang XH; Zhang SF; Wu HY; Gao J; Wang XH; Gao TH
    Cell Signal; 2021 Nov; 87():110093. PubMed ID: 34302955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vandetanib-induced inhibition of neuroblastoma cell migration and invasion is associated with downregulation of the SDF-1/CXCR4 axis and matrix metalloproteinase 14.
    Ding X; Xiang L; Wang N; Zhao Z; Jin X; Sun Y; Duan W; Wang S; Jin X
    Oncol Rep; 2014 Mar; 31(3):1165-74. PubMed ID: 24399074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
    Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
    PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro.
    Liu Y; Ren CC; Yang L; Xu YM; Chen YN
    J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization.
    Tang C; Lei X; Xiong L; Hu Z; Tang B
    Cell Death Dis; 2021 Apr; 12(5):422. PubMed ID: 33927188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway.
    Gao XL; Zheng M; Wang HF; Dai LL; Yu XH; Yang X; Pang X; Li L; Zhang M; Wang SS; Wu JB; Tang YJ; Liang XH; Tang YL
    BMC Cancer; 2019 Jul; 19(1):743. PubMed ID: 31357956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLF9 inhibits the proliferation, invasion, and migration of renal cell carcinoma through the SDF-1/CXCR4 axis.
    Yu P; Cheng L; Xia WM; Liu DY; Yu JS; Zhou YF; Zheng YJ
    Kaohsiung J Med Sci; 2023 Jun; 39(6):587-595. PubMed ID: 37010151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological blockage of the CXCR4-CXCL12 axis in endometriosis leads to contrasting effects in proliferation, migration, and invasion.
    Ruiz A; Ruiz L; Colón-Caraballo M; Torres-Collazo BJ; Monteiro JB; Bayona M; Fazleabas AT; Flores I
    Biol Reprod; 2018 Jan; 98(1):4-14. PubMed ID: 29161347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.
    Mühlethaler-Mottet A; Liberman J; Ascenção K; Flahaut M; Balmas Bourloud K; Yan P; Jauquier N; Gross N; Joseph JM
    PLoS One; 2015; 10(5):e0125616. PubMed ID: 25955316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway.
    Yin X; Liu Z; Zhu P; Wang Y; Ren Q; Chen H; Xu J
    J Cell Biochem; 2019 Jun; 120(6):9724-9736. PubMed ID: 30582214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments.
    Liao YX; Fu ZZ; Zhou CH; Shan LC; Wang ZY; Yin F; Zheng LP; Hua YQ; Cai ZD
    Oncol Rep; 2015 Jul; 34(1):33-42. PubMed ID: 25997540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration.
    Boudot A; Kerdivel G; Lecomte S; Flouriot G; Desille M; Godey F; Leveque J; Tas P; Le Dréan Y; Pakdel F
    BMC Cancer; 2014 Jun; 14():407. PubMed ID: 24906407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
    Chen N; Jiang X; Wang J; Wu T; Cheng B; Xia J
    Tumour Biol; 2016 Jan; 37(1):567-75. PubMed ID: 26232325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Csk homologous kinase inhibits CXCL12-CXCR4 signaling in neuroblastoma.
    Zagozdzon R; Fu Y; Avraham HK
    Int J Oncol; 2008 Mar; 32(3):619-23. PubMed ID: 18292939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
    Zhao S; Wang J; Qin C
    J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].
    Jiang YP; Wu XH; Xing HY; DU XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):403-7. PubMed ID: 17697603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
    Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
    PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative genomic analyses of CXCR4: transcriptional regulation of CXCR4 based on TGFbeta, Nodal, Activin signaling and POU5F1, FOXA2, FOXC2, FOXH1, SOX17, and GFI1 transcription factors.
    Katoh M; Katoh M
    Int J Oncol; 2010 Feb; 36(2):415-20. PubMed ID: 20043076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.
    Meier R; Mühlethaler-Mottet A; Flahaut M; Coulon A; Fusco C; Louache F; Auderset K; Bourloud KB; Daudigeos E; Ruegg C; Vassal G; Gross N; Joseph JM
    PLoS One; 2007 Oct; 2(10):e1016. PubMed ID: 17925864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.